Molecular staging of gynecological cancer: What is the future? - Test2 - elhamkhani - TriplyDB

Molecular staging of gynecological cancer: What is the future?

Molecular staging of gynecological cancer: What is the future?

http://www.wikidata.org/entity/Q35940829

about

The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers.Frontline treatment of epithelial ovarian cancer.Predicting high-risk endometrioid carcinomas using proteins.

P2860

Q33809605-59776E90-FE73-4E2D-9B0C-06549EA767EB Q38669746-3777F8E3-D476-40AB-984C-8DA29AD88910 Q55368257-B72E10A9-9EBA-4DC7-9099-A2D59E6BA8B8

P2860

Molecular staging of gynecological cancer: What is the future?

http://www.wikidata.org/entity/Q35940829

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Molecular staging of gynecological cancer: What is the future?

@ast

Molecular staging of gynecological cancer: What is the future?

@en

type

label

Molecular staging of gynecological cancer: What is the future?

@ast

Molecular staging of gynecological cancer: What is the future?

@en

prefLabel

Molecular staging of gynecological cancer: What is the future?

@ast

Molecular staging of gynecological cancer: What is the future?

@en

P1433

Q35940829-57A48EBB-01E7-4FB1-85AE-2FD5A7BA182E

P1476

Q35940829-86E783F9-F306-48FC-BF02-171C274593FF

P2093

Q35940829-094B908B-897E-4D9F-B407-294BB7E38628

Q35940829-227752A1-281D-491B-99EA-007C22E5528D

Q35940829-B4887B88-FB37-4502-8AFF-B35762454CD4

P2860

Q35940829-07EEC3A8-A00F-4F07-BB28-D441F80E6CA0

Q35940829-0800B5FA-0B44-4CDE-A57F-89625FFC6978

Q35940829-11E3BA3F-EB88-4D0C-8B53-D5B5EE83E571

Q35940829-132F7045-02DD-4CEB-A622-59CFBFF446E5

Q35940829-142CD3C9-53BF-478D-9132-BEDE1D7798BA

Q35940829-15C9F6CE-F5A0-4F4C-906C-48224597D0A5

Q35940829-16EBE71A-5684-46E9-98E6-28E57D9B7A67

Q35940829-197521B8-568D-45C3-808E-F96F1ACF0EA3

Q35940829-203BB783-B9BE-468B-A40A-7F12E901D5BD

Q35940829-206E7FEF-45A1-4BAE-B5B3-357EA11DBDA4

P304

Q35940829-CB71CFCC-9DD7-43DD-8704-E00686C08F24

P31

Q35940829-6CC944B0-76AC-4968-A25F-4CABDD3695ED

P356

Q35940829-15DDCFE1-36AA-4268-9228-5DC3095E0F1D

P433

Q35940829-F690E9FD-83D1-40A5-90C9-2082ED428B53

P478

Q35940829-6EC96883-0D56-4257-A40A-FE344E1BBA2F

P577

Q35940829-8C8D851A-6151-4AA4-BD07-BF9188B89491

P698

Q35940829-785B2560-DF28-4DA0-8FCA-152BE54B9D9E

P932

Q35940829-BEADD67A-1574-4F09-946B-C30AA32FC7DF

P356

J.BPOBGYN.2015.01.008

P1433

Best Practice & Research: Clinical Obstetrics & Gynaecology

P1476

Molecular staging of gynecological cancer: What is the future?

@en

P2093

David G Mutch

http://www.w3.org/2001/XMLSchema#string

Jaime Prat

http://www.w3.org/2001/XMLSchema#string

Pratibha S Binder

http://www.w3.org/2001/XMLSchema#string

P2860

Endometrial Glandular Dysplasia with Frequent p53 Gene Mutation: A Genetic Evidence Supporting Its Precancer Nature for Endometrial Serous Carcinoma

Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?

Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study.

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas

Integrated genomic analyses of ovarian carcinoma

Integrated genomic characterization of endometrial carcinoma

Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance

Activation and activities of the p53 tumour suppressor protein

FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features

Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study

P304

776-789

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BPOBGYN.2015.01.008

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25934522

http://www.w3.org/2001/XMLSchema#string

P932

4532616

http://www.w3.org/2001/XMLSchema#string